Melatonin and its precursor, L-tryptophan: Influence on pancreatic amylase secretion in vivo and in vitro

Journal of Pineal Research

Volumn 36, Issue 3, 2004, Pages 155-164

  Jaworek, Jolanta ^a   Nawrot, Katarzyna ^a   Konturek, Stanisław J ^a   Leja Szpak, Anna ^a   Thor, Piotr ^a   Pawlik, Wiesław W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Amylase secretion; Cholecystokinin; L tryptophan; Melatonin; Pancreatic acini; Tarazepide

Indexed keywords

AMYLASE; CAPSAICIN; CERULETIDE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; DEVAZEPIDE; LUZINDOLE; MELATONIN; TARAZEPIDE; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMYLASE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE; BILE DUCT FISTULA; BLOOD LEVEL; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; GASTROINTESTINAL TRACT; INSULIN RELEASE; NONHUMAN; PANCREAS FISTULA; PANCREAS JUICE; PANCREAS SECRETION; PINEAL BODY; RAT; VAGOTOMY;

EID: 1842453126     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-079X.2003.00110.x     Document Type: Article

References (35)

1. LERNER AB, CASE JD, TAKAHASHI Y et al. Isolation of melatonin, a pineal factor that lightenes melanocytes. J Am Soc 1958; 80:2587-2590.
2. SHARKEY KM, EASTMAN CI. Melatonin phase shifts circadian rhytms in a placebo-controlled stimulated night-work study. Am J Physiol 2002; 282:R454-R463.
3. OHTA Y, KONGO M, KISHIKAWA T. Melatonin exerts a therapeutic effect on cholestatic liver injury in rats with bile duct ligation. J Pineal Res 2003; 34:119-125.
4. LEE YM, CHEN HR, HSIAO G et al. Protective effect of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002; 33:72-88.
5. YAMAMOTO HE, MOHANAN PV. Melatonin attenuates brain mitochondria DNA damage induced by potassium cyanide in vivo and in vitro. Toxicology 2002; 179:29-36.
6. TAN D, MANCHESTER LC, REITER RJ et al. High physiological level of melatonin in the bile of mammals. Life Sci 1999; 65:2523-2529.
7. BUBENIK GA, HACKER RR, BROWN GM, BARTOS L. Melatonin concentrations in the luminal fluid, mucosa and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res 1999; 26:56-63.
8. BUBENIK GA, BROWN GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of rats. Biol Signals 1997; 6:40-44.
9. THOMAS L, PURVIS CC, DREW JE et al. Melatonin receptors in human fetal brain: 2-[(125)J} iodomelatonin binding and MT1 gene expression. J Pineal Res 2002; 33:218-224.
10. POON AM, CHOW PH, MAK AS, PANG SF. Autoradiographic localization of 2-[(125)J}iodomelatonin bindingin the gastrointestinal tract of mammals including humans and birds. J Pineal Res 1997; 23:5-14.
11. PESCHKE E, FAUTECK JD, MUSSHOFF U et al. Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic and molecular investigations. J Pineal Res 2000; 28:156-164.
12. PICINATO MC, HABER EP, CIPOLLA-NETO J et al. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res 2002; 33:156-160.
13. ANDERSSON AK, SANDLER S. Melatonin protects against streptozocin but not interleukin-1beta-induced damage of rodent pancreatic beta-cells. J Pineal Res 2001; 30:157-165.
14. QI W, TAN DX, REITER RJ et al. Melatonin reduced lipid peroxidation and tissue edema in caerulein-induced acute pancreatitis in rats. Dig Dis Sci 1999; 44:2257-2262.
15. JAWOREK J, LEJA-SZPAK A, BONIOR J et al. Protective effect of melatonin and its precursor; L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia-reperfusion. J Pineal Res 2003; 34:40-52.
16. HOSAKA T, MIMURO T, HAMADA M et al. Stimulatory effect of LH on release of melatonin and activities of its synthetizing enzymes NAT and HIOMT in organ-cultured pineal glands of female rats. Horm Metab Res 2002; 34:441-445.
17. STEFULJ J, HORNER M, GHOSH M et al. Gene expression of the key enzymes in melatonin synthesis in extrapineal tissues in the rat. J Pineal Res 2001; 30:243-247.
18. LA FLEUR SE, KALSBEEK A, WORTEL J et al. Role for the pineal and melatonin in glucose homeostasis: pinealectomy increases night-time glucose concentrations. J Neuroendocrinol 2001; 13:1025-1032.
19. FABIS M, PRUSZYŃSKA E, MACKOWIAK P. In vivo and in situ action of melatonin on insulin secretion and some metabolic implications in the rat. Pancreas 2000; 25:166-169.
20. KONTUREK SJ, PEPERA J, ZABIELSKI K et al. Brain-gut axis in pancreatic secretion and appetite control. J Physiol Pharmacol 2003; 54:293-317.
21. LI Y, HOA Y, OWYANG C. High affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am J Physiol 1997; 273:G679-G685.
22. JAWOREK J, KONTUREK SJ, SZLACHCIC A. The role of CGRP and afferent nerves in the modulation of pancreatic enzyme secretion in the rat. Int J Pancreatol 1997; 22:137-146.
23. ZHANG W, CHEN M, CHEN X et al. Inhibition of pancreatic protein secretion by ghrelin in the rat. J Physiol 2001; 537:231-236.
24. BERNFELD P. Amylases alpha and beta. Meth Enzymol 1955; 5:139-148.
25. BIZOT-ESPIARD JG, DOUBLE A, COUSIN B et al. Lack of melatonin effects on insulin action in normal rats. Horm Metab Res 1998; 30:711-716.
26. KONTUREK SJ, TASLER J, CIESZKOWSKI M, JAWOREK J. Intravenous amino acids and fat stimulate pancreatic secretion. Am J Physiol 1979; 234:E678-E684.
27. NIEBERGALL-ROTH E, TEYSSEN S, SINGER MV. Effects of M1 and CCK antagonists on latency of pancreatic amylase response to intestinal stimulation. Am J Physiol 2000; 279:G411-G416.
28. NIEBERGALL-ROTH E, TEYSSEN S, NIEBEL V, SINGER MV. Pancreatic secretory response to intraileal amino acids studies in dogs with an in situ neurally isolated ileum. Int J Pancreatol 2000; 28:83-90.
29. OKUTANI T, OKABAYASHI Y, KOIDE M et al. Tryptohan modulates exocrine secretory function in rat pancreatic acini. J Gastroenterol 1996; 31:254-259.
30. ZABIELSKI R, LEŚNIEWSKA V, BORLAK J et al. Effect of intraduodenal administration of tarazepide on pancreatic secretion and duodenal EMG in the calves. Regul Peptides 1998; 78:113-123.
31. KONTUREK SJ, TASLER J, CIESZKOWSKI M et al. Effects of non-peptidal CCK receptor antagonist (L-364, 718) on pancreatic responses to cholecystokinin, gastrin, bombesin and meat feeding in dogs. Gut 1989; 30:110-117.
32. STOOR M, KOPPITZ P, SIBAEV A et al. Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. J Pineal Res 2002; 33:101-108.
33. JAWOREK J, KONTUREK SJ, LEJA-SZPAK A et al. Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53:791-804.
34. DUBOCOVICH ML. LUZINDOLE (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1998; 246:902-910.
35. SJOBLOM M, FLEMSTROM G. Melatonin in the duodemnal lumen is a potent stimulant of mucosal bicarbonate secretion. J Pineal Res 2003; 34:288-293.